270 related articles for article (PubMed ID: 2455778)
1. A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Levi JA; Thomson D; Sandeman T; Tattersall M; Raghavan D; Byrne M; Gill G; Harvey V; Burns I; Snyder R
J Clin Oncol; 1988 Jul; 6(7):1154-60. PubMed ID: 2455778
[TBL] [Abstract][Full Text] [Related]
2. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.
Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z
J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
Ozols RF; Ihde DC; Linehan WM; Jacob J; Ostchega Y; Young RC
J Clin Oncol; 1988 Jun; 6(6):1031-40. PubMed ID: 2453619
[TBL] [Abstract][Full Text] [Related]
5. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for favorable outcome in disseminated germ cell tumors.
Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
[TBL] [Abstract][Full Text] [Related]
7. High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
Pinkerton CR; Pritchard J; Spitz L
J Clin Oncol; 1986 Feb; 4(2):194-9. PubMed ID: 2418168
[TBL] [Abstract][Full Text] [Related]
8. Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial Group.
Levi JA; Thomson D; Bishop J; Raghavan D; Tattersall M; Byrne M; Gill G; Harvey V; Snyder R; Dalley D
Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1073-7. PubMed ID: 2474445
[TBL] [Abstract][Full Text] [Related]
9. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Moore DH; Homesley HD; Adcock L
Ann Intern Med; 1989 Jul; 111(1):22-7. PubMed ID: 2472080
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of disseminated germ cell tumors.
Einhorn LH
Cancer; 1987 Aug; 60(3 Suppl):570-3. PubMed ID: 2439185
[TBL] [Abstract][Full Text] [Related]
13. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
[TBL] [Abstract][Full Text] [Related]
14. Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary.
Taylor MH; Depetrillo AD; Turner AR
Cancer; 1985 Sep; 56(6):1341-9. PubMed ID: 2411377
[TBL] [Abstract][Full Text] [Related]
15. Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.
Levi JA; Thomson D; Harvey V; Gill G; Raghavan D; Tattersall M; Snyder R; Burns I; Sandeman T; Byrne M
J Clin Oncol; 1990 Jan; 8(1):27-32. PubMed ID: 2153192
[TBL] [Abstract][Full Text] [Related]
16. [Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study].
Göbel U; Bamberg M; Haas RJ; Bökkerink JP; Brämswig G; Calaminus G; Engert J; Gadner H; Havers W; Janka-Schaub GE
Klin Padiatr; 1989; 201(4):247-60. PubMed ID: 2476583
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up.
Roth BJ; Greist A; Kubilis PS; Williams SD; Einhorn LH
J Clin Oncol; 1988 Aug; 6(8):1239-47. PubMed ID: 2457658
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of extragonadal germ cell tumors.
Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
[TBL] [Abstract][Full Text] [Related]
19. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
20. VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors.
Vugrin D; Whitmore WF; Golbey RB
Cancer; 1983 Mar; 51(6):1072-5. PubMed ID: 6185211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]